Markt geschlossen -
Andere Börsenplätze
|
Nachbörslich 16:27:11 | |||
1.4 SEK | -96.26% | 1.56 | +11.43% |
29.04. | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 | |
29.04. | Immunovia ernennt Lisa Ford zur Direktorin des klinischen Labors | CI |
Performance
1 Tag | +11.43% | ||
3 Monate | -27.79% | ||
6 Monate | +41.56% | ||
Laufendes Jahr | -22.82% | ||
1 Jahr | -60.00% | ||
3 Jahre | -98.73% | ||
5 Jahre | -99.27% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Medizinische Diagnose- und Prüfgeräte
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
-96.26% | -.--% | -22.82% | -60.00% | 6.68 Mio. | ||
+4.51% | +3.14% | -13.12% | -14.60% | 18.53 Mrd. | ||
+5.08% | +1.25% | -39.72% | -48.98% | 2.82 Mrd. | ||
+2.72% | -0.18% | +23.79% | +94.94% | 1.91 Mrd. | ||
+2.44% | -6.75% | +1.29% | +34.40% | 1.65 Mrd. | ||
+1.00% | +1.42% | +28.27% | +16.67% | 1.25 Mrd. | ||
-0.62% | -7.44% | -14.61% | -17.52% | 988 Mio. | ||
+0.37% | -2.08% | -20.31% | -33.76% | 910 Mio. | ||
+1.61% | +3.65% | +2.50% | -17.09% | 786 Mio. | ||
-0.84% | -3.03% | -25.02% | -31.14% | 634 Mio. | ||
-0.43% | +1.10% | +8.25% | +24.73% | 507 Mio. | ||
+2.65% | -.--% | -.--% | -.--% | 481 Mio. | ||
+4.05% | +10.04% | -16.10% | +49.31% | 266 Mio. | ||
+10.37% | +27.37% | -35.29% | -0.82% | 226 Mio. | ||
+0.41% | -7.41% | +13.64% | +170.49% | 125 Mio. | ||
+3.08% | +5.69% | -27.87% | -23.92% | 106 Mio. | ||
Durchschnitt | +3.04% | +0.19% | -8.57% | +8.92% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | +3.56% | -1.50% | -10.52% | -5.99% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | -22.82% | ||
2023 | -93.12% | ||
2022 | -63.26% | ||
2021 | -40.70% | ||
2020 | -32.17% | ||
2019 | -6.79% | ||
2018 | +96.31% |
- Börse
- Aktien
- A2AG0F Aktie
- A2AG0F Aktie
- Kurse Immunovia AB